Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

Semaglutide, the active ingredient in Ozempic and Wegovy, could revolutionize the treatment of alcohol and tobacco-related ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Research found that semaglutide, the active substance in Ozempic and the weight-loss drug Wegovy, could help curb alcohol ...

While medications such as methadone, buprenorphine, and naltrexone are FDA-approved for treating opioid use disorder, they ...

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...